Leonard A. Valentino, MD

Rush University Medical CenterChicago, Illinois - 60612 Rush Presbyterian St. LukesChicago, Illinois - 60612 (312-942-3569) Rush University Medical Center-Pediatric Hematology ...Chicago, Illinois - 60612 Rush University and Rush Children's ...Chicago, Illinois - 60612-3833 |
- CLINICAL TRIALS 6
- CONDITIONS5
- INTERVENTIONS8
- SINCE2006

Survey of Inhibitors in Plasma-Product Exposed Toddlers
November 2009 - November 2014

Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Unilateral Knee Replacement
June 2006 - October 2014

Treatment of Blood Clots in Children With Cancer
February 2010 - March 2012

Study of Recombinant Factor IX Product IB1001 in Subjects With Hemophilia B
January 2009 - April 2010

Rituximab to Treat Severe Hemophilia A
June 2006 - December 2011

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients
September 2007 - December 2010
Thromboembolism
Venous Thromboembolism
Von Willebrand Disease
Hemophilia A
Hemophilia B
Rituximab
Plasma Derived Factor Viii
Recombinant Fviii
Recombinant Protein-Free Factor Viii (Rahf-Pfm)
Fragmin
Ib1001 (On-Demand)
Ib1001 (Prophylaxis)
Alphanate Sd/Ht



